Cargando…
Sphingolipids Are Dual Specific Drug Targets for the Management of Pulmonary Infections: Perspective
Sphingolipids are the major constituent of the mucus secreted by the cells of epithelial linings of lungs where they maintain the barrier functions and prevent microbial invasion. Sphingolipids are interconvertible, and their primary and secondary metabolites have both structural and functional role...
Autores principales: | Sharma, Lalita, Prakash, Hridayesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372786/ https://www.ncbi.nlm.nih.gov/pubmed/28400772 http://dx.doi.org/10.3389/fimmu.2017.00378 |
Ejemplares similares
-
Sphingolipids, mycobacteria and host: Unraveling the tug of war
por: Mohammed, Shakeel Ahmed, et al.
Publicado: (2022) -
Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease
por: Prakash, Hridayesh, et al.
Publicado: (2021) -
Sphingosine-1-Phosphate (S-1P) Promotes Differentiation of Naive Macrophages and Enhances Protective Immunity Against Mycobacterium tuberculosis
por: Nadella, Vinod, et al.
Publicado: (2020) -
Inhibitors of Apoptosis Protein Antagonists (Smac Mimetic Compounds) Control Polarization of Macrophages during Microbial Challenge and Sterile Inflammatory Responses
por: Nadella, Vinod, et al.
Publicado: (2018) -
Altered sphingolipid pathway in SARS-CoV-2 infected human lung tissue
por: Khan, Rabisa J., et al.
Publicado: (2023)